KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Acadia Pharmaceuticals (ACAD) Non Operating Income: 2014-2024

Historic Non Operating Income for Acadia Pharmaceuticals (ACAD) over the last 11 years, with Dec 2024 value amounting to -$13.7 million.

  • Acadia Pharmaceuticals' Non Operating Income rose 2.95% to $593,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.2 million, marking a year-over-year decrease of 578.52%. This contributed to the annual value of -$13.7 million for FY2024, which is 368.45% down from last year.
  • Acadia Pharmaceuticals' Non Operating Income amounted to -$13.7 million in FY2024, which was down 368.45% from $5.1 million recorded in FY2023.
  • Over the past 5 years, Acadia Pharmaceuticals' Non Operating Income peaked at $5.1 million during FY2023, and registered a low of -$13.7 million during FY2024.
  • Over the past 3 years, Acadia Pharmaceuticals' median Non Operating Income value was $3.5 million (recorded in 2022), while the average stood at -$1.7 million.
  • In the last 5 years, Acadia Pharmaceuticals' Non Operating Income spiked by 44.24% in 2023 and then slumped by 368.45% in 2024.
  • Yearly analysis of 5 years shows Acadia Pharmaceuticals' Non Operating Income stood at $4.2 million in 2020, then slumped by 32.11% to $2.9 million in 2021, then grew by 23.98% to $3.5 million in 2022, then skyrocketed by 44.24% to $5.1 million in 2023, then crashed by 368.45% to -$13.7 million in 2024.